These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18094404)

  • 21. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of microglia in the chick embryo spinal cord: implications in the regulation of motoneuronal survival and death.
    Calderó J; Brunet N; Ciutat D; Hereu M; Esquerda JE
    J Neurosci Res; 2009 Aug; 87(11):2447-66. PubMed ID: 19382239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options.
    Ocaña A; Pandiella A
    Clin Cancer Res; 2008 Feb; 14(4):961-70. PubMed ID: 18281527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3K and mTOR inhibitors: a new generation of targeted anticancer agents.
    Brachmann S; Fritsch C; Maira SM; García-Echeverría C
    Curr Opin Cell Biol; 2009 Apr; 21(2):194-8. PubMed ID: 19201591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy.
    Güner D; Belka C; Daniel PT
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):319-26. PubMed ID: 12871077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How many ways to die? How many different models of cell death?
    Melino G; Knight RA; Nicotera P
    Cell Death Differ; 2005 Nov; 12 Suppl 2():1457-62. PubMed ID: 16247490
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting important pathways in head and neck cancer: from the bench to the clinic.
    Santos ES; Perez C; Donald CE; Raez LE
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is a step backwards in S-phase-targeted chemotherapy a step forward?
    Queiroz de Oliveira PE; Tomko RJ; Lazo JS
    Mol Interv; 2008 Jun; 8(3):137-40. PubMed ID: 18693192
    [No Abstract]   [Full Text] [Related]  

  • 30. Progression-free survival remains debatable endpoint in cancer trials.
    Tuma R
    J Natl Cancer Inst; 2009 Nov; 101(21):1439-41. PubMed ID: 19828873
    [No Abstract]   [Full Text] [Related]  

  • 31. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A; Bozko P; Sabisz M
    Chem Rev; 2009 Jul; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molecular mechanism regulating effect of anti-cancer agents].
    Saya H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):1-5. PubMed ID: 19151557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical perspectives of cell death: where we are and where to go..
    Zhivotovsky B; Orrenius S
    Apoptosis; 2009 Apr; 14(4):333-5. PubMed ID: 19238546
    [No Abstract]   [Full Text] [Related]  

  • 34. Is TRAIL the holy grail of cancer therapy?
    Newsom-Davis T; Prieske S; Walczak H
    Apoptosis; 2009 Apr; 14(4):607-23. PubMed ID: 19194800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the EGFR and the PKB pathway in cancer.
    Klein S; Levitzki A
    Curr Opin Cell Biol; 2009 Apr; 21(2):185-93. PubMed ID: 19216065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin in cancer-related anemia.
    Fenner MH; Ganser A
    Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 38. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of cell death 2000.
    Zakeri Z; Lockshin RA; Martínez-A C
    Cell Death Differ; 2000 Dec; 7(12):1276-7. PubMed ID: 11175265
    [No Abstract]   [Full Text] [Related]  

  • 40. Connexin-related signaling in cell death: to live or let die?
    Decrock E; Vinken M; De Vuyst E; Krysko DV; D'Herde K; Vanhaecke T; Vandenabeele P; Rogiers V; Leybaert L
    Cell Death Differ; 2009 Apr; 16(4):524-36. PubMed ID: 19197295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.